摘要
目的:探究以纳米碳作为手术时的示踪剂,利用腹腔镜进行中低位直肠癌手术进行治疗的效果。方法:以2006年6月-2012年6月的36例利用纳米碳引导下腹腔镜中低位直肠癌根治术进行治疗的患者为治疗组,选取同期54例采用腹腔镜下中低位直肠癌根治术进行治疗的患者为对照组。对两组患者的治疗效果进行统计并对比分析。结果:治疗组患者手术时间、术中出血量、胃肠道恢复时间短于对照组,差异有统计学意义(P<0.05),肿块距下缘距离两组比较差异无统计学意义(P>0.05);治疗组患者平均检获的淋巴结数(13.77±3.35)多于对照组,平均小于5 cm的淋巴结数量(9.22±1.34)明显多于对照组,平均阳性淋巴结检获数(3.68±0.93)多于对照组,差异均有统计学意义(P<0.05);术后治疗组患者并发症发生率为8.33%,对照组并发症发生率为11.11%,两组比较差异无统计学意义(字2=1.018,P>0.05)。结论:利用纳米碳引导腹腔镜中低位直肠癌根治术综合效果较好,无明显并发症产生。
Objective：To investigate clinical effect analysis of nanocarbon guided laparoscopic surgery applied in low colorectal cancer, to provide a reference for clinical treatment.Method：36 cases of patients with colorectal cancer were selected from June 2006 to June 2012, they were implemented with lower use of nano-carbon boot,they were set as treatment group, 54 cases in the same period were selected as control group, they were implemented with low adoption of laparoscopic.Two groups of patients were compared on treatment results.Result：Operative time, blood loss, gastrointestinal recovery time in treatment group were shorter than those of the control group,the differences were statistically significant（P〈0.05）, the distance tumor from the lower edge of two groups was not statistically significant（P〉0.05）;the average number of lymph nodes in treatment group was（13.77±3.35）,more than the control group,the mean number of lymph nodes smaller than 5 cm was（9.22±1.34）,significantly more than the control group, the mean number of positive lymph nodes were（3.68±0.93）, more in the control group, the differences were statistically significant above comparison（P〈0.05）;postoperative complication rate in treatment group was 8.33%, complication rate in the control group was 11.11%,the difference was not statistically significant（ 字2=1.018,P〈0.05）.Conclusion：The use of nanotechnology in low carbon guided laparoscopic colorectal cancer resection has good clinical effect and safety.
出处
《中国医学创新》
CAS
2014年第35期130-132,共3页
Medical Innovation of China
关键词
纳米碳
腹腔镜
直肠癌
疗效
Nano-carbon
Laparoscopy
Colorectal cancer
Efficacy
